# Post Marketing Follow Up Study To Evaluate Performance Safety Quality of Menopausal Transition Women Treated With Ainara

> **NCT04362371** · NA · COMPLETED · sponsor: **Italfarmaco** · enrollment: 73 (actual)

## Conditions studied

- Vaginal Disease

## Interventions

- **DEVICE:** Ainara

## Key facts

- **NCT ID:** NCT04362371
- **Lead sponsor:** Italfarmaco
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-27
- **Primary completion:** 2019-12-09
- **Final completion:** 2019-12-09
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2021-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04362371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04362371, "Post Marketing Follow Up Study To Evaluate Performance Safety Quality of Menopausal Transition Women Treated With Ainara". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04362371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*